Viogen Ment 50 mg is a pharmaceutical-grade preparation that contains trestolone acetate (often referred to simply as “MENT”) at 50 mg per millilitre in a vial format. The product is associated with Viogen Pharmaceuticals’ range of hormone‑related compounds and is categorised under androgenic/anabolic steroid compounds.

Active Ingredient:

Trestolone Acetate (7α‑methyl‑19‑nortestosterone) – a synthetic androgen and anabolic steroid (AAS) derivative.

Trestolone acetate is a chemically modified form of nortestosterone designed to act as a potent androgen receptor agonist. In pharmacological studies, the parent compound trestolone (MENT) has been investigated as a potent androgen with both anabolic and androgenic activity. It has been researched for potential uses such as male hormonal birth control and androgen replacement therapy, although it has not been approved for general medical use in major regulatory jurisdictions.

Mechanism of Action:

Viogen Ment 50 mg works through activation of the androgen receptor (AR)—the same receptor that endogenous testosterone targets. By binding to these receptors in muscle, bone and other tissues, trestolone acetate can stimulate protein synthesis, promote androgenic effects and influence secondary male characteristics. Due to its structural modifications, trestolone is more resistant to metabolic breakdown than some other anabolic steroids, which can enhance its activity.

Typical Uses (Experimental/Research Context):

Hormone replacement: Investigated as a potential treatment for symptoms of low testosterone or hypogonadism.

Male contraception: Has been studied for its ability to suppress sperm production by influencing the release of gonadotropic hormones (LH and FSH), potentially inducing temporary infertility.

Bodybuilding/Strength Sports (non‑medical contexts): Occasionally encountered in research and athletic environments for its anabolic properties to support muscle growth and recovery, though this is off‑label and not medically sanctioned.

Pharmacological Profile:

Class: Androgen; Anabolic steroid; Progestogen (due to structural progestogenic activity).

Formulation: Typically supplied as an injectable solution in a vial (commonly 50 mg/mL).

Safety and Side Effects:

Because trestolone acetate is a powerful androgenic compound, its use—especially outside of controlled clinical or research settings—carries significant risk. Potential effects include suppression of natural testosterone production, possible impacts on fertility, altered lipid profiles and cardiovascular parameters, hormonal imbalances, and other steroid‑associated side effects. Serious side effects may also arise from misuse, high doses, or prolonged use beyond investigational parameters. As with all anabolic steroids, monitoring by qualified healthcare professionals is essential.

Regulatory Status: Trestolone acetate (MENT) has been described extensively in scientific literature and pharmacological databases as an investigational compound that has not been widely approved as a licensed prescription drug. In many countries, AAS compounds are controlled substances and their possession or use without a valid prescription may be restricted or illegal. Users and researchers should be aware of local regulations.